BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 9547633)

  • 1. Protection from radiation-induced oral mucositis by a mouth rinse containing the prostaglandin E1 analog, misoprostol: a placebo controlled double blind clinical trial.
    Hanson WR; Marks JE; Reddy SP; Simon S; Mihalo WE; Tova Y
    Adv Exp Med Biol; 1997; 400B():811-8. PubMed ID: 9547633
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of topical misoprostol to reduce radiation-induced mucositis: results of a randomized, double-blind, placebo-controlled trial.
    Veness MJ; Foroudi F; Gebski V; Timms I; Sathiyaseelan Y; Cakir B; Tiver KW
    Australas Radiol; 2006 Oct; 50(5):468-74. PubMed ID: 16981945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Radiation-induced mucositis and neutrophil granulocytes in oral mucosa].
    Schmidberger H; Rave-Fränk M; Kim S; Hille A; Pradier O; Hess CF
    Strahlenther Onkol; 2003 Oct; 179(10):667-72. PubMed ID: 14566474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can prophylactic application of immunoglobulin decrease radiotherapy-induced oral mucositis?
    Mose S; Adamietz IA; Saran F; Thilmann C; Heyd R; Knecht R; Böttcher HD
    Am J Clin Oncol; 1997 Aug; 20(4):407-11. PubMed ID: 9256900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind, placebo-controlled, randomised trial of active manuka honey and standard oral care for radiation-induced oral mucositis.
    Bardy J; Molassiotis A; Ryder WD; Mais K; Sykes A; Yap B; Lee L; Kaczmarski E; Slevin N
    Br J Oral Maxillofac Surg; 2012 Apr; 50(3):221-6. PubMed ID: 21636188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sucralfate mouth washing in the prevention of radiation-induced mucositis: a placebo-controlled double-blind randomized study.
    Makkonen TA; Boström P; Vilja P; Joensuu H
    Int J Radiat Oncol Biol Phys; 1994 Aug; 30(1):177-82. PubMed ID: 8083112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, double-blind, placebo-controlled trial of misoprostol for oral mucositis secondary to high-dose chemotherapy.
    Lalla RV; Gordon GB; Schubert M; Silverman S; Hutten M; Sonis ST; LeVeque F; Peterson DE
    Support Care Cancer; 2012 Aug; 20(8):1797-804. PubMed ID: 21964618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Planned preoperative irradiation and surgery for advanced cancer of the oral cavity, pharynx and larynx.
    Roswit B; Spiro RH; Kolson H; Lin PY
    Am J Roentgenol Radium Ther Nucl Med; 1972 Jan; 114(1):59-62. PubMed ID: 5009416
    [No Abstract]   [Full Text] [Related]  

  • 9. Oropharyngeal mucositis complicating bone marrow transplantation: prognostic factors and the effect of chlorhexidine mouth rinse.
    Weisdorf DJ; Bostrom B; Raether D; Mattingly M; Walker P; Pihlstrom B; Ferrieri P; Haake R; Goldman A; Woods W
    Bone Marrow Transplant; 1989 Jan; 4(1):89-95. PubMed ID: 2647192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sucralfate in the prevention of radiation-induced oral mucositis.
    Cengiz M; Ozyar E; Oztürk D; Akyol F; Atahan IL; Hayran M
    J Clin Gastroenterol; 1999 Jan; 28(1):40-3. PubMed ID: 9916664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of Wobe-Mugos E for reduction of oral mucositis after radiotherapy : results of a prospective, randomized, placebo-controlled, triple-blind phase III multicenter study.
    Dörr W; Herrmann T;
    Strahlenther Onkol; 2007 Mar; 183(3):121-7. PubMed ID: 17340069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benzydamine HCl for prophylaxis of radiation-induced oral mucositis: results from a multicenter, randomized, double-blind, placebo-controlled clinical trial.
    Epstein JB; Silverman S; Paggiarino DA; Crockett S; Schubert MM; Senzer NN; Lockhart PB; Gallagher MJ; Peterson DE; Leveque FG
    Cancer; 2001 Aug; 92(4):875-85. PubMed ID: 11550161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of concurrent granulocyte macrophage-colony stimulating factor on radiation-induced mucositis in head and neck cancer patients: a double-blind placebo-controlled prospective phase III study by Radiation Therapy Oncology Group 9901.
    Ryu JK; Swann S; LeVeque F; Scarantino CW; Johnson D; Chen A; Fortin A; Pollock J; Kim H; Ang KK
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):643-50. PubMed ID: 17293228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucosal secretion changes during radiotherapy in the oral cavity.
    Aziz L; Ebenfelt A
    Clin Oral Investig; 2007 Sep; 11(3):293-6. PubMed ID: 17522903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Locoregional recurrences of HNSCC: place of re-irradiations].
    Bourhis J; Temam S; Wibault P; Lusinchi A; de Crevoisier B; Janot R; Bobin S
    Bull Cancer; 2004 Nov; 91(11):871-3. PubMed ID: 15582891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Radiation-induced osteomyelitis of the mandible].
    Bünger B
    Laryngorhinootologie; 1990 Jun; 69(6):316-9. PubMed ID: 2378658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effectiveness of a saline mouth rinse regimen and education programme on radiation-induced oral mucositis and quality of life in oral cavity cancer patients: A randomised controlled trial.
    Huang BS; Wu SC; Lin CY; Fan KH; Chang JT; Chen SC
    Eur J Cancer Care (Engl); 2018 Mar; 27(2):e12819. PubMed ID: 29315944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylaxis of radiation-associated mucositis in conventionally treated patients with head and neck cancer: a double-blind, phase III, randomized, controlled trial evaluating the clinical efficacy of an antimicrobial lozenge using a validated mucositis scoring system.
    El-Sayed S; Nabid A; Shelley W; Hay J; Balogh J; Gelinas M; MacKenzie R; Read N; Berthelet E; Lau H; Epstein J; Delvecchio P; Ganguly PK; Wong F; Burns P; Tu D; Pater J
    J Clin Oncol; 2002 Oct; 20(19):3956-63. PubMed ID: 12351592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of quality of life and oral function of patients participating in a phase II study of radioprotection of oral and pharyngeal mucosa by the prostaglandin E(1) analog misoprostol (RTOG 96-07).
    Johnson DJ; Scott CB; Marks JE; Seay TE; Atkins JN; Berk LB; Meoz RT; Wheeler JA
    Int J Radiat Oncol Biol Phys; 2002 Dec; 54(5):1455-9. PubMed ID: 12459369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute mucositis in the stimulated oral mucosa of patients during radiotherapy for head and neck cancer.
    Maciejewski B; Zajusz A; Pilecki B; Swiatnicka J; Skladowski K; Dorr W; Kummermehr J; Trott KR
    Radiother Oncol; 1991 Sep; 22(1):7-11. PubMed ID: 1947216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.